Prescription GLP-1 receptor agonists have undergone rigorous, large-scale clinical trials showing significant efficacy in lowering blood glucose levels, promoting substantial weight loss, and even offering cardiovascular benefits in some cases
Although the cardioprotective effects of GLP-1RA are more established in atherosclerotic cardiovascular disease than in heart failure, recent studies demonstrate a modest but clinically meaningful benefit in heart failure with preserved ejection fraction (HFpEF), particularly among obese patients
Note that protein needs should be individualized, and those with kidney disease should follow their provider's guidance
Le Glutathion MCCM agit comme un antioxydant efficace dans notre corps, en prvenant les dommages causs par les radicaux libres et en renforant le systme immunitaire
10.3389/fcvm.2021.829151/full 137
Integrating transcriptomics and metabolomics to elucidate the mechanism by which taurine protects against DOX-induced depression